Economic evaluation and access strategy development for the 20-valent pneumococcal conjugate vaccine (PCV20) in Spanish adults

Publication:
Economic evaluation and access strategy development for the 20-valent pneumococcal conjugate vaccine (PCV20) in Spanish adults

dc.contributor.advisor	Rejas Gutiérrez, Javier
dc.contributor.author	Martínez Martínez, Néstor
dc.contributor.departamento	UC3M. Departamento de Economía	es
dc.date.accessioned	2022-06-08T15:00:53Z
dc.date.available	2022-06-08T15:00:53Z
dc.date.issued	2021-10-29
dc.description.degree	Máster en Evaluación Sanitaria y Acceso al Mercado	es
dc.identifier.uri	https://hdl.handle.net/10016/35042
dc.rights	Atribución-NoComercial-SinDerivadas 3.0 España
dc.rights.accessRights	open access
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/es/
dc.subject.eciencia	Economía	es
dc.subject.other	Pneumococcal infection	en
dc.subject.other	Pneumococcal pneumonia	en
dc.subject.other	Cost-effectiveness	en
dc.subject.other	PCV20	en
dc.subject.other	Pneumococcal vaccines	en
dc.subject.other	20-valent pneumococcal vaccine	en
dc.title	Economic evaluation and access strategy development for the 20-valent pneumococcal conjugate vaccine (PCV20) in Spanish adults	en
dc.type	master thesis	*
dc.type.hasVersion	VoR	*
dspace.entity.type	Publication